Key Facts

PIPS Key Facts
Active Substance
  • Zibotentan
Invented Name
Not available at present
PIP Number MHRA-100081-PIP01-21
Pharmaceutical form(s)
  • Tablet
  • hard capsule
Therapeutic area
Therapeutic area:
  • Other: Renal Disease
Conditions / Indications
Conditions / Indications:
  • Treatment of Chronic Kidney Disease
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Zibotentan;DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE.pdf
Published Date 17/12/2021